The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Glycerol Phenylbutyrate Drugs Market Research Report 2025
Synopsis
Glycerol phenylbutyrate (USAN), trade name Ravicti, is a medication used in the treatment of certain inborn urea cycle disorders. The medication works by preventing the harmful buildup of ammonia in the body.
The global Glycerol Phenylbutyrate Drugs market was valued at US$ 325.7 million in 2023 and is anticipated to reach US$ 556.5 million by 2030, witnessing a CAGR of 6.8% during the forecast period 2024-2030.
The Ravicti market is driven by the increasing prevalence of urea cycle disorders (UCD), a group of rare genetic conditions affecting ammonia metabolism. Ravicti, a medication containing glycerol phenylbutyrate, is used to manage UCD by reducing ammonia levels in the blood. The drug's efficacy and safety profile have contributed to its growing adoption among UCD patients. Moreover, advancements in diagnostic methods and increased awareness of UCD have led to early diagnosis and treatment initiation, further propelling market growth. However, challenges include the high cost of the medication, potential side effects, and the need for continued research to optimize treatment outcomes and expand its use in various populations. Overcoming these challenges and providing access to affordable and effective treatments will be vital for the sustained growth of the Ravicti market.
This report aims to provide a comprehensive presentation of the global market for Glycerol Phenylbutyrate Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glycerol Phenylbutyrate Drugs.
Report Scope
The Glycerol Phenylbutyrate Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Unit) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Glycerol Phenylbutyrate Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glycerol Phenylbutyrate Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Horizon Pharma
Segment by Type
25ml
50ml
Segment by Application
Hospital
Pharmacy
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Glycerol Phenylbutyrate Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Glycerol Phenylbutyrate Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Glycerol phenylbutyrate (USAN), trade name Ravicti, is a medication used in the treatment of certain inborn urea cycle disorders. The medication works by preventing the harmful buildup of ammonia in the body.
The global Glycerol Phenylbutyrate Drugs market was valued at US$ 325.7 million in 2023 and is anticipated to reach US$ 556.5 million by 2030, witnessing a CAGR of 6.8% during the forecast period 2024-2030.
The Ravicti market is driven by the increasing prevalence of urea cycle disorders (UCD), a group of rare genetic conditions affecting ammonia metabolism. Ravicti, a medication containing glycerol phenylbutyrate, is used to manage UCD by reducing ammonia levels in the blood. The drug's efficacy and safety profile have contributed to its growing adoption among UCD patients. Moreover, advancements in diagnostic methods and increased awareness of UCD have led to early diagnosis and treatment initiation, further propelling market growth. However, challenges include the high cost of the medication, potential side effects, and the need for continued research to optimize treatment outcomes and expand its use in various populations. Overcoming these challenges and providing access to affordable and effective treatments will be vital for the sustained growth of the Ravicti market.
This report aims to provide a comprehensive presentation of the global market for Glycerol Phenylbutyrate Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glycerol Phenylbutyrate Drugs.
Report Scope
The Glycerol Phenylbutyrate Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Unit) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Glycerol Phenylbutyrate Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glycerol Phenylbutyrate Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Horizon Pharma
Segment by Type
25ml
50ml
Segment by Application
Hospital
Pharmacy
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Glycerol Phenylbutyrate Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Glycerol Phenylbutyrate Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Glycerol Phenylbutyrate Drugs Market Overview
1.1 Product Overview and Scope of Glycerol Phenylbutyrate Drugs
1.2 Glycerol Phenylbutyrate Drugs Segment by Type
1.2.1 Global Glycerol Phenylbutyrate Drugs Market Value Comparison by Type (2024-2030)
1.2.2 25ml
1.2.3 50ml
1.3 Glycerol Phenylbutyrate Drugs Segment by Application
1.3.1 Global Glycerol Phenylbutyrate Drugs Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Glycerol Phenylbutyrate Drugs Market Size Estimates and Forecasts
1.4.1 Global Glycerol Phenylbutyrate Drugs Revenue 2019-2030
1.4.2 Global Glycerol Phenylbutyrate Drugs Sales 2019-2030
1.4.3 Global Glycerol Phenylbutyrate Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Glycerol Phenylbutyrate Drugs Market Competition by Manufacturers
2.1 Global Glycerol Phenylbutyrate Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Glycerol Phenylbutyrate Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Glycerol Phenylbutyrate Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Glycerol Phenylbutyrate Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Glycerol Phenylbutyrate Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Glycerol Phenylbutyrate Drugs, Product Type & Application
2.7 Glycerol Phenylbutyrate Drugs Market Competitive Situation and Trends
2.7.1 Glycerol Phenylbutyrate Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Glycerol Phenylbutyrate Drugs Players Market Share by Revenue
2.7.3 Global Glycerol Phenylbutyrate Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Glycerol Phenylbutyrate Drugs Retrospective Market Scenario by Region
3.1 Global Glycerol Phenylbutyrate Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Glycerol Phenylbutyrate Drugs Global Glycerol Phenylbutyrate Drugs Sales by Region: 2019-2030
3.2.1 Global Glycerol Phenylbutyrate Drugs Sales by Region: 2019-2024
3.2.2 Global Glycerol Phenylbutyrate Drugs Sales by Region: 2025-2030
3.3 Global Glycerol Phenylbutyrate Drugs Global Glycerol Phenylbutyrate Drugs Revenue by Region: 2019-2030
3.3.1 Global Glycerol Phenylbutyrate Drugs Revenue by Region: 2019-2024
3.3.2 Global Glycerol Phenylbutyrate Drugs Revenue by Region: 2025-2030
3.4 North America Glycerol Phenylbutyrate Drugs Market Facts & Figures by Country
3.4.1 North America Glycerol Phenylbutyrate Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Glycerol Phenylbutyrate Drugs Sales by Country (2019-2030)
3.4.3 North America Glycerol Phenylbutyrate Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Glycerol Phenylbutyrate Drugs Market Facts & Figures by Country
3.5.1 Europe Glycerol Phenylbutyrate Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Glycerol Phenylbutyrate Drugs Sales by Country (2019-2030)
3.5.3 Europe Glycerol Phenylbutyrate Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Glycerol Phenylbutyrate Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Glycerol Phenylbutyrate Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Glycerol Phenylbutyrate Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Glycerol Phenylbutyrate Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Glycerol Phenylbutyrate Drugs Market Facts & Figures by Country
3.7.1 Latin America Glycerol Phenylbutyrate Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Glycerol Phenylbutyrate Drugs Sales by Country (2019-2030)
3.7.3 Latin America Glycerol Phenylbutyrate Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Glycerol Phenylbutyrate Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Glycerol Phenylbutyrate Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Glycerol Phenylbutyrate Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Glycerol Phenylbutyrate Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Glycerol Phenylbutyrate Drugs Sales by Type (2019-2030)
4.1.1 Global Glycerol Phenylbutyrate Drugs Sales by Type (2019-2024)
4.1.2 Global Glycerol Phenylbutyrate Drugs Sales by Type (2025-2030)
4.1.3 Global Glycerol Phenylbutyrate Drugs Sales Market Share by Type (2019-2030)
4.2 Global Glycerol Phenylbutyrate Drugs Revenue by Type (2019-2030)
4.2.1 Global Glycerol Phenylbutyrate Drugs Revenue by Type (2019-2024)
4.2.2 Global Glycerol Phenylbutyrate Drugs Revenue by Type (2025-2030)
4.2.3 Global Glycerol Phenylbutyrate Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Glycerol Phenylbutyrate Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Glycerol Phenylbutyrate Drugs Sales by Application (2019-2030)
5.1.1 Global Glycerol Phenylbutyrate Drugs Sales by Application (2019-2024)
5.1.2 Global Glycerol Phenylbutyrate Drugs Sales by Application (2025-2030)
5.1.3 Global Glycerol Phenylbutyrate Drugs Sales Market Share by Application (2019-2030)
5.2 Global Glycerol Phenylbutyrate Drugs Revenue by Application (2019-2030)
5.2.1 Global Glycerol Phenylbutyrate Drugs Revenue by Application (2019-2024)
5.2.2 Global Glycerol Phenylbutyrate Drugs Revenue by Application (2025-2030)
5.2.3 Global Glycerol Phenylbutyrate Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Glycerol Phenylbutyrate Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Horizon Pharma
6.1.1 Horizon Pharma Corporation Information
6.1.2 Horizon Pharma Description and Business Overview
6.1.3 Horizon Pharma Glycerol Phenylbutyrate Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Horizon Pharma Glycerol Phenylbutyrate Drugs Product Portfolio
6.1.5 Horizon Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Glycerol Phenylbutyrate Drugs Industry Chain Analysis
7.2 Glycerol Phenylbutyrate Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Glycerol Phenylbutyrate Drugs Production Mode & Process
7.4 Glycerol Phenylbutyrate Drugs Sales and Marketing
7.4.1 Glycerol Phenylbutyrate Drugs Sales Channels
7.4.2 Glycerol Phenylbutyrate Drugs Distributors
7.5 Glycerol Phenylbutyrate Drugs Customers
8 Glycerol Phenylbutyrate Drugs Market Dynamics
8.1 Glycerol Phenylbutyrate Drugs Industry Trends
8.2 Glycerol Phenylbutyrate Drugs Market Drivers
8.3 Glycerol Phenylbutyrate Drugs Market Challenges
8.4 Glycerol Phenylbutyrate Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
